This roundtable addresses: Leon Jun Tang, PhD The four major areas of cell therapy moving forward include autologous, allogeneic, point of care and in vivo CAR-T. Gene therapy has been studied for more than 40 years and can help stop or slow the effects of disease on the most basic level of the human bodyour genes. BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and . Join us for an hour and fifteen minute guided walking tour to explore New York Citys first Landmark District Brooklyn Heights. Director, Cellular Therapy Program and Associate Professor of Medicine, Harvard Medical School, Massachusetts General Hospital. ISCT 2023 International Society of Cell & Gene Therapy, CAR-T Therapy: The Future of Regenerative Immunotherapy. Mutations in the GBA1 gene, observed in about 10% of Parkinson's patients, are one of the most common risk factors for the neurodegenerative disease, raising the risk by up to about 20 times. Every event ensures the content you receive and the connections you access will truly give you the insight and inspiration you need to drive the gene therapy community forward. Gene Therapy conference listings are indexed in scientific databases like Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, EBSCO, BASE, WorldCAT, Sherpa/RoMEO, Compendex, Elsevier, Scopus, Thomson Reuters (Web of Science), RCSI Library, UGC Approved Journals, ACM, CAS, ACTA, CASSI, ISI, SCI, ESCI, SCIE, Springer, Wiley, Taylor Francis, and The Science Citation Index (SCI). CSO, Mnemo Therapeutics, TRACK C: HARNESSING THE FULL POTENTIAL OF TUMOR REACTIVE LYMPHOCYTES, Barbara Lavery Minute. London Precision ADVANCE, a collection of interconnected services and complementary teams across Precision for Medicine, Project Farma, and Precision Value & Health are uniquely focused on the complexities of clinical, regulatory, manufacturing, and commercial needs to successfully . Gene therapies take years to go from theoretical concepts, to preclinical trials, to clinical trials, and, finally, into actual treatments that can improve the lives of patients. 2 Day Conference + Workshop Day OR Discussion Day $3,197. Gene Forum takes the honour to invite you to the "15th International Genetics & Gene Therapy'' which will be held on July 26-27, 2023 Rome, Italy. Hanson Wade products are united by a deep level of research and precise understanding of scientific content. Neville Sanjana, PhD January 17th - 20th 2023 I Miami Beach Convention Center. In this roundtable, we provide an update on key questions, challenges and progress. Over 600 attendees. Three track choices covering new cell type approaches, neoantigen targeting approaches and clinical advancements. We use cookies to ensure that we give you the best experience on our website. Every event ensures the content you receive and the connections you access will truly give you the insight and . On this outing, we will also stop along the Brooklyn Heights Promenade for truly breathtaking views of lower Manhattan, New York Harbor and the Brooklyn Bridge. COO and President, Be Bio, Michael Klichinsky, PharmD, PhD Copyright 2023 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. ---. Location: Paris, France Dates: May 31 - June 3, 2023 Booth: 107 Link: ISCT 2023 Latest Updates January 11, 2023 World Cancer Day 2023 January 5, 2023 2022: A Year in Review December 8, 2022 $1,100 ! With the beginning of a new year and the resetting of conference budgets, what better time to secure your Ebube Orazulume en LinkedIn: 3rd Gene Therapy Comparability Summit 2023 6th Gene Therapy for Rare Disorders 2023 | Event Series The Promise of The Gene Therapy Event Series Gene therapies are revolutionizing the treatment of a host of devastating diseases, giving hope to patients who previously had no therapeutic options. This presentation will focus on a platform approach to drive the discovery of novel gene functions in T-cells or other immune cells that enhance cell function to drive enhanced persistence and enhance anti-tumor activity. The meeting will provide conference attendees updates on recent gene therapy innovations from vector designs to product launch. Executive Director, Global Regulatory Affairs, Kite, a Gilead Company, Jordan Schecter, MD We value your ROI and will work with you directly on your specific goals and targets thats why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated. Gene Therapy Conferences in USA 2022/2023/2024 is an indexed listing of upcoming meetings, seminars, congresses, workshops, programs, continuing CME courses, trainings, summits, and weekly, annual or monthly symposiums. The Wayne County native and member of Calvary Baptist Church was a 1966 Jesup High School graduate and received two associate's degrees, one from South Georgia College in Douglas while playing baseball and then one at John A. Gupton School of Mortuary Science in Nashville . Managing Director, Next Pillar Consulting, Roundtable #3: Cell Therapy Combinations: Key Questions, Challenges and Progress. As the industry-leading rare gene therapy meeting, the Gene Therapy for Rare Disorders is back at a landmark moment for the field. With our extensive marketing experience and strategy, your partnership with Advancing Gene Therapy will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. Register for the 6th Gene Therapy for Rare Disorders Summit 2023. In addition, the summit covers emerging and related fields including Gene Editing & CRISPR, Cell Therapies, Gene Therapy for Cancer, Immunotherapy, Rare diseases, Blood Disorders, Neurological Disorders, Toxicology Studies, advances in manufacturing, regulatory and medical affairs, Commercialization Strategies, Business Models and Market Access. Your registration provides access to the presentations across all 8 tracks, allowing you to create an agenda tailored specifically for your needs. If you continue to use this site we will assume that you are happy with it. Advisors | A common bottleneck during regulatory interactions is in the manufacturing side of gene therapy programs. Hanson Wade American Society of Gene & Cell Therapy. Advertising opportunities on Gene Therapy Net include standard size banners as well as text ads. . Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene. Senior Director, Immuno-Oncology and Cellular Therapy Translational Research, BMS, Michael Kalos, PhD Gene therapy, cell therapy and gene editing are fields of biomedical research with a similar goal in mind: To treat disease by changing our genetic makeup. We speak to hundreds of biopharmaceutical experts from industry and academia every day. January 11, 2023. Sales Europe Disruptive Strategies to Overcome the Limitations of Cell Therapy Including: Biopharma Advancements in Cell Therapy CSO, Verismo Therapeutics, TRACK B: NEOANTIGEN & SHARED TARGETING APPROACHES, Reagan Jarvi, PhD All Hanson Wade products focus on structuring data, content, and insight primarily in emerging and complex niches of drug discovery and development to provide the definitive quality and comprehensive coverage needed to get better drugs to patients faster. Chief Scientific Officer and Co-Founder, Lupagen, Andrew Scharenberg, MD We will: Bring together multinational regulatory bodies, including the, Enhance regulatory understanding to better inform clinical and manufacturing programmes, Navigate new regulatory designations and accelerated pathways, Designing and implementing safe and effective clinical trials, understanding the process behind defining primary endpoints, The operational intricacies behind rare gene therapy trials, Gearing up for registrational clinical trials, Leveraging innovative platforms, using the latest advances in technology to improve manufacturing efficiency, Navigating key bottlenecks in rare disease CMC to scale up effectively, Demonstrating comparability to regulatory bodies in light of process changes, Define the value of your rare gene therapy, Effectively set up your cross-functional team to be prepared for launch, Ensure rare disease patients have access to gene therapies, and the practicalities surrounding early access. You can also make a donation by PayPal and support the Gene Therapy Net website. High-throughput Approaches to Novel Gene Functions in T-Cells T: (+1) 617 455 4188 Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. With August came the green light for bluebird bios Zynteglo in the US, the first FDA approval for a gene therapy in over three years. Translatable vectorsovercoming the size limitations of aav vectors to progress . They all bring tremendous potential, challenges and limitations. Advanced Therapies Week is the destination for developers, investors and solution providers whose goal is to bring cell and gene therapies to patients. Register today for the 2023 conference - April 12-14, 2023 in Barcelona, Spain! Terms and Conditions, New York Marriott at the Brooklyn Bridge, Brooklyn, NY, Investor Perspective on the State of the Current Market and Impact on the IO Cell Therapy Field, Addressing the Translational Research Paradigm And Generating the Right Information From your Translational Studies to Have Greater Impact, Senior Director, Immuno-Oncology and Cellular Therapy Translational Research, Cell Therapy Combinations: Key Questions, Challenges and Progress. About Us | Core Faculty Member / Associate Professor of Biology / Associate Professor of Neuroscience and Physiology, New York Genome Center / New York University / NYU Grossman School of Medicine. Conferences | Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Pre-Filled Syringes and Injectable Drug Devices Europe, Cell & Gene Therapy Conferences at PepTalk 2023, Transdermal and Microneedle Drug Delivery, Next Generation Ophthalmic Drug Delivery Summit, 2nd Annual mRNA-Based Therapeutics Summit, 2nd Allogeneic Cell Therapies Summit Europe, 3rd TGF- for Immuno-Oncology Drug Development Summit, 6th Annual Cell & Gene Therapy Innovation Summit, Retinal Vascular Disease Drug Development Summit, 11th Alzheimers & Parkinsons (Gene Therapy) Drug Development Summit, 3rd Annual Gene Therapy for Muscular Disorders Summit, GENAP Summit 2023 - Gene & Cell Therapy Aseptic Processing Technology, 6th Antigen-Specific Immune Tolerance Summit, Cell & Gene Therapy Research & Development Congress Asia, 4th Supply Chain and Logistics for Cell Therapies Summit, 12th Spring Meeting of the International Society for BioProcess Technology, 6th Annual Gene Therapy for Rare Disorders 2023 Summit, Reuters Pharma USA 2023 - Cell and Gene Therapies, International Bioprocessing and Biologics 2023 - Cell and Gene Therapies, 2nd LNP Formulation & Process Development Summit 2023 - Gene Therapy delivery, mRNA Process Development & Manufacturing Summit Europe, The Economist's Cell & Gene Therapy summit, 4th Gene Therapy Analytical Development Europe Summit, ISBioTech Nucleic Acids meeting - Production of DNA and RNA Biotherapeutics, 2nd Next Generation RNA Therapeutics Summit, American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, Global Biologics Cell and Gene Legal Summit, Annual meeting of the Netherlands Society of Gene & Cell Therapy, Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting, 31th Annual Meeting of the European Society of Gene & Cell Therapy (ESGCT), Your conference not listed? SVP, Immuno-Oncology and Cellular Therapy, BMS, Michael Kalos, PhD Join our mailing list to receive exclusive content and offers. If you are unable to attend the summit at any given time, we will transfer your ticket to next year. Here we learn about the process of developing a treatment. The 6th Annual Gene Therapy for Rare Disorders 2023 Summit remains devoted to showcasing the top case studies and strategic learnings from the past year. This rapid-style session features updates from companies specializing in CAR-T modifications on progress, challenges and next steps. President & CEO, Notch Therapeutics, Bob Valamehr, PhD, MBA American Society of Gene & Cell Therapy. Submit an Abstract. Gene Therapy Conferences 2023 10 - 12 January 2023 Pre-Filled Syringes and Injectable Drug Devices Europe London, UK 16 - 20 January 2023 Cell & Gene Therapy Conferences at PepTalk 2023 San Diego, CA 23 - 24 January 2023 Transdermal and Microneedle Drug Delivery London, UK 24 - 26 January 2023 Next Generation Ophthalmic Drug Delivery Summit Dr Isabelle Rivire provides a progress report on manufacturing platforms for cell therapy including Autologous, Allogeneic, In Vivo and Point of Care. Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. CSO & COO, TScan Therapeutics, Zach Taylor Mechanisms Driving CAR-T CSO, Obsidian Therapeutics, Stewart Abbot, PhD The International Journal of Molecular and Cellular Therapeutics. Molecular Therapy is the leading journal for gene and cell therapy research, publishing important peer-reviewed research and cutting-edge reviews and commentaries. The meeting will provide conference attendees updates on recent gene therapy innovations from vector designs to product launch. Cell therapy combinations present many challenges due to risk and costs. Special Early Bird Rate Ends in.. Day. Rinehart & Sons Calvin Gene Rinehart Sr. JesupCalvin Gene Rinehart Sr., 74, of Jesup died on Oct. 28, 2022. SVP, Research, BlueRock Therapeutics, TRACK B: MODIFIED TCRs; SYNTHETIC CIRCUITS, Kole Roybal, PhD This roundtable will address how to practically establish translational infrastructure that can generate actionable and informative data to support clinical trials. Marcela Maus, MD, PhD Will there ever be a place for 2 types of cells? Isabelle Rivire, PhD Gene Therapy for Rare Disorders: Searchlight is a vital year-round knowledge sharing and problem solving network designed to accelerate the safe delivery of gene therapies to rare disorder patients. 20800 Swenson Dr. The mission of the Gene Therapy Event Series is to focus on the most challenging problems facing every aspect of the industry, sourcing leading experts with innovative solutions and distilling this into market-leading conferences. What key problems do each need to address? Suite 300 with more than 20 presentations across two days, the cell & gene therapy research & development congress asia will provide a platform for leading biopharma and biotech leaders, academicians and researchers to discuss topics on emerging advances in the field of cell and gene therapy, the regenerative potential of stem cells, application of t- Over 1 attendees. Additional topics include: Arjun Goyal, MD, MPhil, MBA A full-service partner for plasmid DNA, viral . Our BPI 2022 agenda includes 8 conference tracks covering novel science across all phases of bioprocessing for biologics, cell & gene therapies. By continuing to use this website, you accept our use of cookies. February 7, 2023 IO Cell therapy regulatory updates to include data of volume, How to optimize engagement with the FDA at the right level, What industry can do better as they bring forward new and innovative cell therapy programs, 3 things the FDA would like to see in cell therapy to move towards democratizing access and affordability. CBO, Gracell Biotechnologies, High-Throughput Approaches to Discover Novel Gene Functions in T-Cells. Click here to suggest. This session will focus on key learnings cleaned from the full clinical development pathway- from first-in-human through launch to commercialization for each of the to-date approved autologous cell therapy products. CART clinical trials have been ongoing for more than 15 years. Co-founder & CSO, Carisma Therapeutics, Moutih Rafei, PhD Co-founder & CEO, Outpace Bio, Leah Sibener, PhD Copyright 2023 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. After a successful year of approvals and with even more decisions anticipated for 2023, improving clarity over regulatory expectations and maintaining an open dialogue between industry and regulatory bodies remains paramount.